Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Authors:
- Michaela A.A. FuchsMFMichaela A.A. Fuchs
- Alexander GrabnerAGAlexander Grabner
- Melody ShiMSMelody Shi
- Susan L. MurraySMSusan L. Murray
- Emily J. BurkeEBEmily J. Burke
- Nejla LaticNLNejla Latic
- Venkataramana ThiriveediVTVenkataramana Thiriveedi
- Jatin RoperJRJatin Roper
- Shintaro IdeSIShintaro Ide
- Koki AbeKAKoki Abe
- Hiroki KitaiHKHiroki Kitai
- Tomokazu SoumaTSTomokazu Souma
Open Access
- 17 December 2024
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (4)
Abstract
Vitamin D regulates mineral homeostasis. The most biologically active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D), is synthesized by CYP27B1 from 25-dihydroxyvitamin D (25D) and is inactivated by CYP24A1. Human monogenic diseases and genome-wide association studies support a critical role for CYP24A1 in regulation of mineral homeostasis, but little is known about its tissue-specific effects. Here, we describe the responses of mice with inducible global deletion, kidney-specific, and intestine-specific deletion of Cyp24a1 to dietary calcium challenge and chronic kidney disease (CKD). Global and kidney-specific Cyp24a1 deletion caused similar syndromes of systemic vitamin D intoxication: elevated circulating 1,25D, 25D, and fibroblast growth factor 23 (FGF23), activation of vitamin D target genes in the kidney and intestine, hypercalcemia, and suppressed parathyroid hormone (PTH). In contrast, mice with intestine-specific Cyp24a1 deletion demonstrated activation of vitamin D target genes exclusively in the intestine, despite no changes in systemic vitamin D levels. In response to a high calcium diet, PTH was suppressed, despite normal serum calcium. In mice with CKD, intestinal Cyp24a1 deletion decreased PTH and FGF23 without precipitating hypercalcemia. These results implicate kidney CYP24A1 in systemic vitamin D regulation while independent local effects of intestinal CYP24A1 could be targeted to treat secondary hyperparathyroidism in CKD.Keywords
Funding Information
- Norges Idrettshøgskole (R01DK132060)
- Norges Idrettshøgskole (R01DK123097)
This publication has 62 references indexed in Scilit:
- Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: Insights into substrate specificity and membrane bound structure–functionArchives of Biochemistry and Biophysics, 2007
- Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary DiseaseCirculation, 2005
- Altered Pharmacokinetics of 1α,25-Dihydroxyvitamin D3and 25-Hydroxyvitamin D3in the Blood and Tissues of the 25-Hydroxyvitamin D-24-Hydroxylase (Cyp24a1) Null MouseEndocrinology, 2005
- Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2005
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- Tissue‐specific and inducible Cre‐mediated recombination in the gut epitheliumGenesis, 2004
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004
- Deficient Mineralization of Intramembranous Bone in Vitamin D-24-Hydroxylase-Ablated Mice Is Due to Elevated 1,25-Dihydroxyvitamin D and Not to the Absence of 24,25-Dihydroxyvitamin D*Endocrinology, 2000
- Targeted inactivation of vitamin D hydroxylases in miceBone, 1999
- Regulatory Sequences of the Mouse Villin Gene That Efficiently Drive Transgenic Expression in Immature and Differentiated Epithelial Cells of Small and Large IntestinesJournal of Biological Chemistry, 1999